US Stock MarketDetailed Quotes

Harvard Bioscience (HBIO)

Watchlist

5.565
+0.155+2.87%

Close May 13 16:00 ET

5.570
+0.005+0.09%

Post 16:11 ET

25.10MMarket Cap-2.59P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Harvard Bioscience (HBIO) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Total revenue

-4.68%20.76M

-8.06%86.55M

-3.34%23.74M

-6.28%20.59M

-11.46%20.45M

-11.17%21.77M

-16.14%94.14M

-12.78%24.56M

-13.38%21.97M

-19.69%23.1M

Operating revenue

-4.68%20.76M

-8.06%86.55M

-3.34%23.74M

-6.28%20.59M

-11.46%20.45M

-11.17%21.77M

-16.14%94.14M

-12.78%24.56M

-13.38%21.97M

-19.69%23.1M

Cost of revenue

-11.25%8.51M

-6.93%36.64M

-9.31%9.56M

-6.90%8.57M

-9.74%8.92M

-1.54%9.59M

-14.75%39.37M

-10.85%10.55M

-13.45%9.21M

-18.26%9.88M

Gross profit

0.49%12.24M

-8.87%49.91M

1.15%14.17M

-5.83%12.02M

-12.75%11.53M

-17.52%12.18M

-17.11%54.77M

-14.17%14.01M

-13.32%12.77M

-20.72%13.22M

Operating expense

-3.33%13.18M

-18.31%49.81M

-20.46%12.25M

-18.56%11.78M

-19.19%12.15M

-15.22%13.64M

-4.99%60.98M

-4.05%15.39M

-7.66%14.46M

-5.28%15.04M

Selling and administrative expenses

-1.17%10.04M

-15.44%36.96M

-9.67%9.21M

-16.76%8.79M

-20.58%8.8M

-14.42%10.16M

-6.65%43.71M

-10.82%10.2M

-8.49%10.56M

-3.90%11.08M

-Selling and marketing expense

7.32%5.34M

-13.49%19.22M

-5.60%5.09M

-16.40%4.61M

-15.87%4.54M

-15.80%4.97M

-7.68%22.21M

-12.59%5.4M

-3.73%5.52M

-12.67%5.4M

-General and administrative expense

-9.32%4.7M

-17.45%17.74M

-14.24%4.12M

-17.16%4.18M

-25.04%4.26M

-13.05%5.19M

-5.55%21.49M

-8.74%4.8M

-13.19%5.04M

6.22%5.69M

Research and development costs

0.22%2.33M

-15.19%8.83M

-6.23%2.18M

-16.95%2.13M

-16.64%2.19M

-19.55%2.32M

-11.54%10.41M

-26.10%2.33M

-6.99%2.57M

-11.19%2.63M

Depreciation amortization depletion

-29.31%820K

-23.37%4.03M

-32.38%850K

-35.91%855K

-12.70%1.16M

-12.98%1.16M

-4.89%5.26M

-9.37%1.26M

-1.98%1.33M

-4.18%1.33M

-Depreciation and amortization

-29.31%820K

-23.37%4.03M

-32.38%850K

-35.91%855K

-12.70%1.16M

-12.98%1.16M

-4.89%5.26M

-9.37%1.26M

-1.98%1.33M

-4.18%1.33M

Other operating expenses

----

2,169.01%1.61M

----

Operating profit

35.38%-939K

101.61%100K

239.33%1.93M

114.45%245K

65.99%-619K

-10.66%-1.45M

-427.93%-6.21M

-590.43%-1.38M

-81.67%-1.7M

-328.64%-1.82M

Net non-operating interest income expense

-85.21%-1.73M

-39.06%-4.92M

-99.83%-2.36M

-12.85%-966K

-5.61%-791K

-24.23%-933K

1.53%-3.54M

-48.61%-1.18M

2.95%-856K

20.40%-749K

Non-operating interest expense

85.21%1.73M

39.06%4.92M

99.83%2.36M

12.85%966K

5.61%791K

24.23%933K

-1.53%3.54M

48.61%1.18M

-2.95%856K

-20.40%749K

Other net income (expense)

98.68%-640K

-2,640.82%-52.57M

-187.95%-2.77M

78.71%-413K

-18.71%-844K

-1,900.33%-48.41M

-123.28%-1.92M

633.50%3.15M

-254.83%-1.94M

63.59%-711K

Gain on sale of security

----

-152.06%-1.59M

--0

----

82.23%-281K

Special income (charges)

99.51%-235K

---48.68M

-115.57%-217K

73.18%-48K

19.68%-200K

-4,891.20%-48.22M

--0

--1.39M

---179K

---249K

-Less：Restructuring and merger&acquisition

152.69%235K

--188K

--17K

-73.18%48K

-92.42%30K

--93K

----

--179K

--396K

-Less:Impairment of capital assets

--0

--47.95M

--0

--47.95M

--0

-Less:Other special charges

----

--541K

--200K

----

215.65%170K

-82.30%171K

----

---147K

Other non- operating income (expenses)

-109.84%-405K

-1,096.62%-3.89M

-245.31%-2.56M

79.27%-365K

-255.80%-644K

-35.92%-193K

-43.17%-325K

629.82%1.76M

-4,013.33%-1.76M

51.34%-181K

Income before tax

93.49%-3.31M

-391.95%-57.39M

-643.05%-3.2M

74.75%-1.13M

31.28%-2.25M

-1,032.78%-50.79M

-356.38%-11.67M

153.49%590K

-699.11%-4.49M

-56.34%-3.28M

Income tax

125.77%117K

-192.70%-686K

-162.41%-357K

-68.81%97K

107.93%28K

-316.19%-454K

-13.85%740K

-20.00%572K

-54.06%311K

68.43%-353K

Net income

93.20%-3.42M

-357.07%-56.7M

-15,916.67%-2.85M

74.36%-1.23M

22.04%-2.28M

-972.43%-50.34M

-263.25%-12.41M

100.99%18K

-287.57%-4.8M

-198.67%-2.93M

Net income continuous Operations

93.20%-3.42M

-357.07%-56.7M

-15,916.67%-2.85M

74.36%-1.23M

22.04%-2.28M

-972.43%-50.34M

-263.25%-12.41M

100.99%18K

-287.57%-4.8M

-198.67%-2.93M

Minority interest income

Net income attributable to the parent company

93.20%-3.42M

-357.07%-56.7M

-15,916.67%-2.85M

74.36%-1.23M

22.04%-2.28M

-972.43%-50.34M

-263.25%-12.41M

100.99%18K

-287.57%-4.8M

-198.67%-2.93M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

93.20%-3.42M

-357.07%-56.7M

-15,916.67%-2.85M

74.36%-1.23M

22.04%-2.28M

-972.43%-50.34M

-263.25%-12.41M

100.99%18K

-287.57%-4.8M

-198.67%-2.93M

Basic earnings per share

93.26%-0.77

-357.14%-12.8

-0.6

72.73%-0.3

28.57%-0.5

-938.18%-11.42

-250.00%-2.8

-266.67%-1.1

-250.00%-0.7

Diluted earnings per share

93.26%-0.77

-357.14%-12.8

-0.6

72.73%-0.3

28.57%-0.5

-938.18%-11.42

-250.00%-2.8

-266.67%-1.1

-250.00%-0.7

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Total revenue	-4.68%20.76M	-8.06%86.55M	-3.34%23.74M	-6.28%20.59M	-11.46%20.45M	-11.17%21.77M	-16.14%94.14M	-12.78%24.56M	-13.38%21.97M	-19.69%23.1M
Operating revenue	-4.68%20.76M	-8.06%86.55M	-3.34%23.74M	-6.28%20.59M	-11.46%20.45M	-11.17%21.77M	-16.14%94.14M	-12.78%24.56M	-13.38%21.97M	-19.69%23.1M
Cost of revenue	-11.25%8.51M	-6.93%36.64M	-9.31%9.56M	-6.90%8.57M	-9.74%8.92M	-1.54%9.59M	-14.75%39.37M	-10.85%10.55M	-13.45%9.21M	-18.26%9.88M
Gross profit	0.49%12.24M	-8.87%49.91M	1.15%14.17M	-5.83%12.02M	-12.75%11.53M	-17.52%12.18M	-17.11%54.77M	-14.17%14.01M	-13.32%12.77M	-20.72%13.22M
Operating expense	-3.33%13.18M	-18.31%49.81M	-20.46%12.25M	-18.56%11.78M	-19.19%12.15M	-15.22%13.64M	-4.99%60.98M	-4.05%15.39M	-7.66%14.46M	-5.28%15.04M
Selling and administrative expenses	-1.17%10.04M	-15.44%36.96M	-9.67%9.21M	-16.76%8.79M	-20.58%8.8M	-14.42%10.16M	-6.65%43.71M	-10.82%10.2M	-8.49%10.56M	-3.90%11.08M
-Selling and marketing expense	7.32%5.34M	-13.49%19.22M	-5.60%5.09M	-16.40%4.61M	-15.87%4.54M	-15.80%4.97M	-7.68%22.21M	-12.59%5.4M	-3.73%5.52M	-12.67%5.4M
-General and administrative expense	-9.32%4.7M	-17.45%17.74M	-14.24%4.12M	-17.16%4.18M	-25.04%4.26M	-13.05%5.19M	-5.55%21.49M	-8.74%4.8M	-13.19%5.04M	6.22%5.69M
Research and development costs	0.22%2.33M	-15.19%8.83M	-6.23%2.18M	-16.95%2.13M	-16.64%2.19M	-19.55%2.32M	-11.54%10.41M	-26.10%2.33M	-6.99%2.57M	-11.19%2.63M
Depreciation amortization depletion	-29.31%820K	-23.37%4.03M	-32.38%850K	-35.91%855K	-12.70%1.16M	-12.98%1.16M	-4.89%5.26M	-9.37%1.26M	-1.98%1.33M	-4.18%1.33M
-Depreciation and amortization	-29.31%820K	-23.37%4.03M	-32.38%850K	-35.91%855K	-12.70%1.16M	-12.98%1.16M	-4.89%5.26M	-9.37%1.26M	-1.98%1.33M	-4.18%1.33M
Other operating expenses	----	----	----	----	----	----	2,169.01%1.61M	----	----	----
Operating profit	35.38%-939K	101.61%100K	239.33%1.93M	114.45%245K	65.99%-619K	-10.66%-1.45M	-427.93%-6.21M	-590.43%-1.38M	-81.67%-1.7M	-328.64%-1.82M
Net non-operating interest income expense	-85.21%-1.73M	-39.06%-4.92M	-99.83%-2.36M	-12.85%-966K	-5.61%-791K	-24.23%-933K	1.53%-3.54M	-48.61%-1.18M	2.95%-856K	20.40%-749K
Non-operating interest expense	85.21%1.73M	39.06%4.92M	99.83%2.36M	12.85%966K	5.61%791K	24.23%933K	-1.53%3.54M	48.61%1.18M	-2.95%856K	-20.40%749K
Other net income (expense)	98.68%-640K	-2,640.82%-52.57M	-187.95%-2.77M	78.71%-413K	-18.71%-844K	-1,900.33%-48.41M	-123.28%-1.92M	633.50%3.15M	-254.83%-1.94M	63.59%-711K
Gain on sale of security	----	----	----	----	----	----	-152.06%-1.59M	--0	----	82.23%-281K
Special income (charges)	99.51%-235K	---48.68M	-115.57%-217K	73.18%-48K	19.68%-200K	-4,891.20%-48.22M	--0	--1.39M	---179K	---249K
-Less：Restructuring and merger&acquisition	152.69%235K	--188K	--17K	-73.18%48K	-92.42%30K	--93K	----	----	--179K	--396K
-Less:Impairment of capital assets	--0	--47.95M	--0	--0	--0	--47.95M	--0	--0	--0	--0
-Less:Other special charges	----	--541K	--200K	----	215.65%170K	-82.30%171K	----	----	----	---147K
Other non- operating income (expenses)	-109.84%-405K	-1,096.62%-3.89M	-245.31%-2.56M	79.27%-365K	-255.80%-644K	-35.92%-193K	-43.17%-325K	629.82%1.76M	-4,013.33%-1.76M	51.34%-181K
Income before tax	93.49%-3.31M	-391.95%-57.39M	-643.05%-3.2M	74.75%-1.13M	31.28%-2.25M	-1,032.78%-50.79M	-356.38%-11.67M	153.49%590K	-699.11%-4.49M	-56.34%-3.28M
Income tax	125.77%117K	-192.70%-686K	-162.41%-357K	-68.81%97K	107.93%28K	-316.19%-454K	-13.85%740K	-20.00%572K	-54.06%311K	68.43%-353K
Net income	93.20%-3.42M	-357.07%-56.7M	-15,916.67%-2.85M	74.36%-1.23M	22.04%-2.28M	-972.43%-50.34M	-263.25%-12.41M	100.99%18K	-287.57%-4.8M	-198.67%-2.93M
Net income continuous Operations	93.20%-3.42M	-357.07%-56.7M	-15,916.67%-2.85M	74.36%-1.23M	22.04%-2.28M	-972.43%-50.34M	-263.25%-12.41M	100.99%18K	-287.57%-4.8M	-198.67%-2.93M
Minority interest income
Net income attributable to the parent company	93.20%-3.42M	-357.07%-56.7M	-15,916.67%-2.85M	74.36%-1.23M	22.04%-2.28M	-972.43%-50.34M	-263.25%-12.41M	100.99%18K	-287.57%-4.8M	-198.67%-2.93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	93.20%-3.42M	-357.07%-56.7M	-15,916.67%-2.85M	74.36%-1.23M	22.04%-2.28M	-972.43%-50.34M	-263.25%-12.41M	100.99%18K	-287.57%-4.8M	-198.67%-2.93M
Basic earnings per share	93.26%-0.77	-357.14%-12.8	-0.6	72.73%-0.3	28.57%-0.5	-938.18%-11.42	-250.00%-2.8	0	-266.67%-1.1	-250.00%-0.7
Diluted earnings per share	93.26%-0.77	-357.14%-12.8	-0.6	72.73%-0.3	28.57%-0.5	-938.18%-11.42	-250.00%-2.8	0	-266.67%-1.1	-250.00%-0.7
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm